Growth hormone therapy in the Prader-Willi syndrome

Archives of Disease in Childhood

Volumn 88, Issue 4, 2003, Pages 283-285

  Paterson, W F ^a   Donaldson, M D C ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; BODY COMPOSITION; BRAIN DEVELOPMENT; BRAIN DISEASE; CARDIOPULMONARY INSUFFICIENCY; CHILD; CHROMOSOME 15; CLINICAL ARTICLE; CRYPTORCHISM; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DRUG INDICATION; FAILURE TO THRIVE; GENE LOSS; GROWTH; HUMAN; HYPOGONADISM; HYPOTHALAMUS; MORBID OBESITY; MUSCLE HYPOTONIA; NEWBORN; PORTAL HYPERTENSION; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; SEPSIS; SKIN DISEASE;

BODY COMPOSITION; CHILD; CHILD, PRESCHOOL; GROWTH; HUMAN GROWTH HORMONE; HUMANS; PRADER-WILLI SYNDROME; RECOMBINANT PROTEINS;

EID: 0037384847     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.4.283     Document Type: Review

References (24)

1. Donaldson MDC. Natural history of Prader-Willi syndrome. Pharmacia International Growth Database Report No 20: Biannual Report, 2002.
2. Cassidy SB, Schwartz S. Prader-Willi and Angelman Syndromes. Medicine 1998;77:140-51.
3. Donaldson MDC, Chu CE, Cooke A, et al. The Prader-Willi syndrome. Arch Dis Child 1994;70:58-63.
4. Butler MG, Meaney FJ. Standards for selected anthropometric measurements in Prader-Willi syndrome. Pediatrics 1991;88:853-60.
5. Wollmann HA, Schultz U, Grauer ML, et al. Reference values for height and weight in Prader-Willi syndrome based on 315 patients. Eur J Pediatr 1998;157:634-42.
6. Nagai T, Matsuo N, Kayanuma Y, et al. Standard growth curves for Japanese patients with Prader-Willi syndrome. Am J Med Genet 2000;95:130-4.
7. Hauffa BP, Schlippe G, Roos M, et al. Spontaneous growth in German children and adolescents with genetically confirmed Prader-Willi syndrome. Acta Paediatr 2000;89:1302-11.
8. Brambilla P, Bosio L, Manzoni P, et al. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am J Clin Nutr 1997;65:1369-74.
9. Schoeller DA, Levitsky LL, Bandini LG, et al. Energy expenditure and body composition in Prader-Willi syndrome. Metabolism 1988;37:115-20.
10. Eiholzer U, Blum W, Molinari L. Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. J Pediatr 1999;134:222-5.
11. Holm VA, Pipes PL. Food and children with Prader-Willi syndrome. Am J Dis Child 1976;130:1063-7.
12. Angulo M, Castro-Magana M, Uy J. Pituitary evaluation and growth hormone treatment in Prader-Willi syndrome. J Pediatr Endocrinol 1991;4:167-73.
13. Grosso S, Cioni M, Buoni S, et al. Growth hormone secretion in Prader-Willi syndrome. J Endocrinol Invest 1998;21:418-22.
14. Carrel AL, Myers SE, Whitman BY, et al. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. J Pediatr 1999;134:215-21.
15. Corrias A, Bellone J, Beccaria L, et al. GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. J Endocrinol Invest 2000;23:84-9.
16. Tauber M, Barbeau C, Jouret B, et al. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children. Horm Res 2000;53:279-87.
17. Grugni G, Guzzaloni G, Morabito F. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome. J Endocrinol Invest 2001;24:340-8.
18. Angulo M, Castro-Magana M, Mazur B, et al. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 1996;9:393-400.
19. Argente J, Caballo N, Barrios V, et al. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab 1997;82:2076-83.
20. Miller L, Angulo M, Price D, et al. MR of the pituitary in patients with Prader-Willi syndrome: size determination and imaging findings. Pediatr Radiol 1996;26:43-7.
21. Eiholzer U. Prader-Willi syndrome: effects of human growth hormone treatment. In: Savage MO, ed. Endocrine development, Vol 3. London: Karger, 2001.
22. Lindgren AC, Ritzen EM. Five years of growth hormone treatment in children with Prader Willi syndrome. Acta Paediatr Suppl 1999;88:109-11.
23. Eiholzer U, l'Allemand D. Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after 4 years of therapy. Horm Res 2000;53:185-92.
24. Myers SE, Carrel AL, Whitman BY, et al. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader Willi syndrome. J Pediatr 2000;137:42-9.